Alpha Teknova, Inc. (TKNO) Stock Price, Financials & Summary

Price chart

Sep 18Sep 23Sep 28Oct 1Oct 6Oct 9Oct 14Oct 19

Key dataOct 19, 2026

Open$7.08

From 52W high−27.12%

Volume158126.00

Market cap$365.08M

P/E (TTM)—

P/S (TTM)8.4x

Div yield—

Key dataOct 19, 2026

Open

$7.08

From 52W high

−27.12%

Volume

158126.00

Market cap

$365.08M

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−39.6x

P/E (TTM)

—

RSI (14)

32.3

MomentumView details →

1D Return

−3.95%

YTD Return

+81.97%

SummaryUpdated Jun 1, 2026

Alpha Teknova, Inc. (NASDAQ:TKNO) is a California-based life sciences company founded in 1996 that provides critical reagents and laboratory consumables to the biotechnology and pharmaceutical industries. The company went public in June 2021 and is headquartered in Hollister, California. Alpha Teknova specializes in manufacturing high-quality reagents that enable the discovery, development, and production of biopharmaceutical products including drug therapies, vaccines, and molecular diagnostics.

Ask drillr about Alpha Teknova, Inc. →

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

—

EV/EBITDA

−39.6x

EV/Sales

8.6x

P/S (TTM)

8.4x

P/B (TTM)

5.8x

ProfitabilityView details →

Gross Margin

33.94%

Net Margin

−38.37%

EBITDA Margin

−21.65%

ROE (TTM)

−26.79%

ROA (TTM)

−17.49%

Asset Turnover

0.45x

GrowthView details →

Revenue YoY

+12.27%

EPS YoY

+27.37%

FCF YoY

+31.94%

Revenue CAGR 3Y

−0.73%

EPS CAGR 3Y

+43.86%

EBITDA YoY

+34.47%

MomentumView details →

1D Return

−3.95%

YTD Return

+81.97%

1Y Return

+20.26%

RSI (14)

32.3

vs 50D SMA

−10.65%

vs 200D SMA

+45.46%

Capital & dividendView details →

Debt/Equity

0.44x

Current Ratio

4.49x

Quick Ratio

3.48x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

−$0.06

EPS Surprise

28.82%

Beats (12Q)

9/12

Next Q EPS Est

−$0.09

Avg Surprise (4Q)

21.85%

Rev Surprise

11.26%

Financials snapshotView financials →

Revenue (TTM)

43.70M

Net Income (TTM)

−16.77M

Op. CF (TTM)

−6.07M

Next earningsNov 4, 2026 →

Latest newsMore news →

Teknova and Pluristyx announced that a Type II FDA Drug Master File has been established for the PluriFreeze cryopreservation system, now available for developers to cross-reference.17d ago

Alpha Teknova (TKNO) shares rose 7.1% in the previous trading session on higher-than-average volume.27d ago

Similar companies

Embecta Corp.EMBC Emergent BioSolutions Inc.EBS Wai Yuen Tong Medicine Holdings Limited00897.HK SNDL Inc.SNDL Kamada Ltd.KMDA Canopy Growth CorporationCGC Find similar companies →

Latest newsMore news →

Teknova and Pluristyx announced that a Type II FDA Drug Master File has been established for the PluriFreeze cryopreservation system, now available for developers to cross-reference.17d ago Alpha Teknova (TKNO) shares rose 7.1% in the previous trading session on higher-than-average volume.27d ago Teknova launched the Fill-Tek Dispensing System, a custom manufacturing offering for filling single-use bag orders across multiple sizes and quantities as a single lot.33d ago